Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stanford study finds new method improves chemotherapy survival in mice

16.12.2004


Seeking to find a way to lessen patients’ vulnerability to deadly infections following chemotherapy, researchers at the Stanford University School of Medicine have figured out a way to boost the immune function in animals following such treatments. Their approach involves increasing the pool of cells that give rise to neutrophils, a type of white blood cell that is critical for fighting bacterial and fungal infections but is particularly ravaged by chemotherapy.

"Our approach hadn’t been studied before, which is interesting because it’s a very straightforward concept," said study leader Janice "Wes" Brown, MD, assistant professor of medicine in the divisions of bone marrow transplantation and infectious diseases.

The team reported that an infusion of a type of bone marrow cell from a donor mouse yielded significantly more neutrophils in the laboratory mice a week after a dose of a typical chemotherapeutic agent. The procedure also increased the animals’ ability to fight a deadly fungal infection. The team’s findings appear in the Dec. 15 issue of the journal Blood.



The condition in which neutrophils are lacking is known as neutropenia. It is the leading cause of death among cancer patients that is not related to their tumor. Because of the seriousness of the condition, doctors will reduce chemotherapy doses if they notice an infection developing in the early phases of the disease, which can decrease the efficacy of the cancer treatment. Additionally, resulting fevers and infections during neutropenia must be fought with antibiotics and antifungals, which can be toxic and spur resistance.

"Clinicians see neutropenia all the time and follow the usual protocols of antibiotics and antifungals," said Brown, who is the sole infectious disease consultant for the bone marrow transplantation division. "We thought, ’Why are we just waiting for the neutropenia to resolve or for the patient to develop an infection? Why don’t we try to prevent it?’"

Brown’s group sought to circumvent the problem by adding more of one type of cell-the myeloid progenitor. This cell can follow several routes of development. They can turn into red blood cells, platelets or neutrophils. Using the progenitor cells seems to be more effective than using mature neutrophils, the researchers said.

The researchers gave a single dose of the chemotherapeutic agent 5-fluorouracil to mice, and the next day gave some of the mice an infusion of purified myeloid progenitor cells. They then exposed all of the mice to a fungus that had killed a chemotherapy patient.

One week later, researchers found that the mice treated with the cellular boost had significantly more neutrophils in their spleens, blood and bone marrow than the ones that had not received the infusion. More than half of the treated mice survived, while only a third of the ones without it did.

The study follows on the heels of earlier work by Brown and her team on the effectiveness of this strategy following radiation treatment. That earlier research also showed that the use of myeloid progenitors improved the ability of the mice to survive exposure to a fungus as well as a bacterial infection.

Brown’s group is now looking at combining cellular infusion with clinical strategies of using antifungals or growth factors to stimulate increases in neutrophil numbers. So far in animal studies, she said, it looks like the therapies merge well and will add together for more effective protection.

Brown noted that the use of the myeloid progenitor cells may be preferential to using mature neutrophils for at least two reasons. First, the myeloid progenitors give rise to a broader spectrum of cells, including platelets and red blood cells, which is helpful in restoring normal blood functions. And second, the myeloid progenitors can survive freezing and thus can be more readily available for treatment. By contrast, the mature cells must be infused immediately into a patient following the collection period, which typically takes four hours per session.

"And the good thing is that we have readily isolated these cells from blood samples from donors and patients," Brown said, "so collection of these cells for clinical use doesn’t require the development of new technology."

Mitzi Baker | EurekAlert!
Further information:
http://www.stanford.edu

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Contacting the molecular world through graphene nanoribbons

19.02.2018 | Materials Sciences

When Proteins Shake Hands

19.02.2018 | Materials Sciences

Cells communicate in a dynamic code

19.02.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>